Background-Cardiac resynchronization therapy (CRT) using endocardial left ventricular (LV) pacing may be superior to conventional CRT. We studied the acute hemodynamic response to conventional CRT and LV pacing from different endocardial sites using a combined cardiac MRI and LV noncontact mapping (NCM) protocol to gain insights into the underlying mechanisms. Methods and Results-Fifteen patients (age, 63Ϯ10 years; 12 men) awaiting CRT were studied in a combined x-ray and MRI laboratory. Delayed-enhancement cardiac magnetic resonance was performed to define areas of myocardial fibrosis. Patients underwent an electrophysiological study incorporating endocardial and epicardial LV pacing. Acute hemodynamic response was measured using a pressure wire within the LV cavity to derive LV dP/dt max. NCM was used to define areas of slow conduction. There was a significant improvement in all LV pacing modes versus baseline (PϽ0.001). LV endocardial CRT from the best endocardial site was superior to conventional CRT, with a 79.8Ϯ49.0% versus 59.6Ϯ49.5% increase in LV dP/dt max of from baseline (PϽ0.05). The hemodynamic benefits of pacing were greater when LV stimulation was performed outside of areas of slow conduction defined by NCM (PϽ0.001).
C ardiac resynchronization therapy (CRT) is an established treatment for selected patients with heart failure. However, the mechanisms of benefit remain relatively poorly understood, giving rise to uncertainty about key issues in developing optimal therapeutic strategies tailored to specific patients. A better understanding of these mechanisms may enable us to increase the proportion of patients deriving benefit from CRT because "nonresponder" rates are as high as 30% to 40%. In addition, it may be possible to maximize the clinical response in those patients who do benefit.
Clinical Perspective on p 179
CRT has been considered fundamentally as an electric treatment designed to resynchronize the ventricular activation pattern in the failing heart. Indeed, left ventricular (LV) lead positioning at an electrically delayed site conferred benefits on acute hemodynamic response to CRT, 1 and response to biventricular pacing has been associated with a shorter paced QRS duration. 2 Several studies, most recently by Ypenburg et al, 3 have demonstrated that LV lead positioning concordant with the site of latest mechanical activation is associated with improvements in reverse LV remodeling and prognosis. In keeping with this concept, other investigators have demonstrated using acute hemodynamic studies that the optimal LV lead position varies considerably between patients and may need to be optimized on an individual basis. 4, 5 However, a major limitation of the coronary sinus approach is the limited number of optimal sites available to capture.
Endocardial pacing may be superior to epicardial pacing as it gives rise to a more physiological propagation of both electric and mechanical activation. 6 A second advantage of endocardial pacing is the ability to access a greater variety of sites in the LV than when compared with a transvenous approach via the coronary sinus. This is especially important to avoid areas of ischemic scar because it has been demonstrated that an adverse response to CRT results from pacing in areas of scar. 7 However, areas of slow conduction have been demonstrated using noncontact mapping (NCM) even in the absence of ischemic scar, 8 and this principle may therefore apply to patients with nonischemic cardiomyopathy. These areas are identified qualitatively by the electric activation pattern of the LV endocardium and local conduction velocity or quantitatively either by the low amplitude of local electrograms or using dynamic substrate mapping. 9 Pacing the LV within such areas of slow conduction has been shown to give rise to a lesser hemodynamic response, 10 and this is one mechanism that may account for interindividual variability in CRT response overall. Areas of slow conduction can be identified using delayed-enhancement cardiac magnetic resonance (DE-CMR) imaging in the context of ischemic heart disease. 11 Although myocardial fibrosis may also be detected using DE-CMR in patients with nonischemic cardiomyopathy, 12 it is not known whether zones of slow conduction can reliably be identified using this technique.
Using a combined cardiac MRI and LV NCM mapping protocol, we sought to determine whether endocardial pacing gives rise to a superior acute hemodynamic response compared with epicardial pacing and to gain insights into the underlying mechanisms of benefit. We aimed to determine whether pacing outside zones of slow conduction confers greater benefit and whether these zones could be visualized using DE-CMR.
Methods

Patients
The St Thomas' Hospital local ethics committee approved the study. All patients provided written informed consent. Patients were at least 18 years old and fulfilled conventional criteria for CRT. 13 Patients with hemodynamically significant aortic valve disease, mechanical right heart valve or aortic valve, peripheral vascular disease, atrial arrhythmia, or contraindication to anticoagulation were excluded, being unable to undergo the invasive mapping study. Patients with renal failure (estimated glomerular filtration rate Ͻ30 mL ⅐ kg Ϫ1 ⅐ min Ϫ1 ⅐ 1.73 m Ϫ2 ) were excluded because of the risk of renal injury from iodinated contrast during the invasive study or from gadolinium-based contrast agents used in cardiac MRI.
Baseline assessment included New York Heart Association (NYHA) functional class, 12-lead ECG, and 2D echocardiography. Patients with ischemic and nonischemic cardiomyopathy were studied at least 1 week before undergoing standard CRT. The etiology of heart failure was confirmed on the basis of clinical history, 12-lead ECG, coronary angiogram, and cardiac MRI.
Cardiac MRI Protocol
Cardiac MRI was used to quantify LV function and volumes, and delayed enhancement imaging was performed after the administration of gadolinium-based contrast agent to assess the burden and distribution of myocardial scar or fibrosis. CMR was performed on a 1.5-T scanner (Philips Medical Systems), and delayed enhancement imaging was performed 15 to 20 minutes after the administration of 0.1 to 0.2 mmol/kg gadopentetate dimeglumine (Magnevist, Bayer Healthcare) using conventional inversion recovery techniques. 14
Invasive Electrophysiological and NCM Protocol
The invasive electrophysiological study was performed in a hybrid x-ray/MRI interventional cardiac catheter laboratory. Patients underwent cardiac MRI immediately before transfer to the x-ray environment, allowing registration of MRI, x-ray, and NCM data within the same coordinate space for accurate tissue characterization. Registration of these data sets was performed using methods described previously. 15 Patients were sedated using diazemuls (5 to 10 mg). Bilateral femoral venous access was used to place quadripolar catheters (St Jude Medical) to the high right atrium, His bundle, and right ventricular apex to perform atrial and ventricular sensing and pacing. The coronary sinus (CS) was intubated, and a multipolar catheter (Cardima) was passed to a posterolateral or lateral branch (depending on coronary venous anatomy) to perform epicardial LV pacing as in conventional CRT. An NCM array (St Jude Medical) was passed via the femoral artery retrogradely across the aortic valve to the LV cavity. Through the other femoral artery, a decapolar catheter (St Jude Medical) was passed to the LV cavity to perform endocardial pacing from different sites within the LV (rove catheter). A pressure wire (Radi Medical Systems, Uppsala, Sweden)-a high-fidelity wire acquiring data at 500 Hz-was placed retrograde to the LV cavity to perform acute hemodynamic measurements.
Invasive Electrophysiological Study
Intravenous heparin (70 u/kg) was administered to achieve systemic anticoagulation (target activated clotting time, 300 to 350 seconds). The EnSite 3000 system (St Jude) consists of a 9F multielectrode array mapping catheter that uses the inverse solution method to reconstruct endocardial potentials within the LV cavity. The accuracy of this technique has been validated previously. 16 The chamber geometry is reconstructed using a locator signal from a steerable electrophysiological catheter. The posteroanterior x-ray view showing the position of catheters within the heart during the invasive electrophysiological study is shown in Figure 1 .
A pacing protocol was then performed in the following order (rate, 100 bpm; AV delay, 100 ms; VV simultaneous, DDD mode where applicable): AAI, RV, conventional CRT (BIV-CS), LV endocardial (LV-EN), and BIV endocardial (BIV-EN: RV and LV endocardial). In all modes involving LV endocardial pacing, we positioned the LV rove catheter in a random order in 4 different endocardial positions: These always included anterior, lateral, and posterior sites. Capture was verified in VVI mode at each pacing site. To exclude fusion between intrinsic activation and LV pacing, QRS morphology was analyzed to establish that there was no significant variability when compared with DDD mode. This was also validated with reference to LV pacing by analysis of the activation wave front on NCM.
Hemodynamic and electrophysiological parameters were assessed at baseline and in each pacing mode once steady-state pacing was achieved for a minimum of 1 minute. In between pacing modes, measurement of intrinsic hemodynamics was repeated after at least 30 seconds of sinus rhythm to account for baseline drift. We used the pressure wire to derive real-time mean peak dP/dt max as a marker of LV contractility, with 3 measurements in each pacing mode taken over a minimum of 10 seconds. The change from intrinsic rhythm in acute hemodynamics as a result of pacing was calculated and expressed as a percentage compared with baseline sinus rhythm. Endocardial maps were obtained in sinus rhythm and in each pacing configuration.
Derivation of LV Activation Time
Virtual unipolar electrograms recorded from the endocardial surface were used to measure the duration of LV activation. The electrograms were acquired at 1200 Hz, giving a temporal resolution of 0.83 ms. The high-pass filter was set at 8 Hz. The onset of activation was defined as the first peak negative dV/dt at any point in the LV. The end of LV activation was defined as the time of the latest peak negative unipolar electrogram on the virtual endocardial surface.
Definition of Regions of Slow Conduction
Dynamic substrate mapping (DSM) was performed after completion of the procedure to define areas of consistently low peak negative voltage, using a method validated previously. 9 Zones of slow conduction were delineated as regions that the activation wave front failed to enter, with the endocardial voltage amplitude threshold set at 30% of the maximum endocardial voltage recorded.
Categorization of LV Lead Position
For endocardial and epicardial LV lead positions, the location of the LV lead tip was attributed in a binary fashion to being in or outside the predefined areas of slow conduction using DSM.
The greater number of accessible locations endocardially provided a more robust assessment of the effect of pacing in different regions. We assessed the effect on acute hemodynamics of the endocardial LV lead position in the long axis (divided into basal, midventricular, or apical sites) and in the short axis (divided into anterior, posterior, or lateral sites). The effect of position of the CS lead was not included in this assessment as the CS lead was placed empirically in the posterolateral or lateral vein.
Statistical Analysis
Continuous variables are expressed as mean (SD). Comparisons were made using the Student t test or 1-way ANOVA for independent samples and paired t tests or repeated-measures ANOVA (RMANOVA) for paired samples of more than 1 group. A 2-tailed probability value Ͻ0.05 was considered significant. Statistical analysis was performed using the Statistics Package for the Social Sciences (SPSS) version 15 (SPSS Inc, Chicago, IL) or MedCalc version 11.2 (MedCalc software, Mariakerke, Belgium).
Results
Patient Demographics
Patient demographics of the 15 patients studied are shown in Table 1 and represent a typical cohort suitable for CRT. The majority were nonischemic patients because the invasive electrophysiological study excluded patients with significant peripheral vascular disease. Patients were all in NYHA class III, with left bundle-branch block.
Procedural Success
The invasive electrophysiological protocol was completed in 14 of 15 (93%) patients. In 1 patient, the procedure was abandoned because it was impossible to pass the array into the LV due to tortuosity of the femoral artery. There were no procedural complications.
Acute Hemodynamic Response to Endocardial Versus Epicardial Pacing
The acute hemodynamic response to pacing is shown in Figure 2 . This is displayed as the mean change in mean peak Figure 2 correspond to the optimal LV endocardial site defined as that which produced the greatest hemodynamic benefit. 5 There was a significant improvement in all LV pacing modes compared with sinus rhythm, AAI, and RV pacing (PϽ0.001, RMANOVA). There was additional acute hemodynamic benefit in LV endocardial and BIV endocardial pacing configurations from the optimal site versus conventional CRT delivered from the coronary sinus (BIV-CS mode, PϽ0.05).
Corresponding changes in LV total endocardial activation time and QRS duration (derived from NCM and the surface ECG, respectively) are shown in Figure 3 . LV total activation time (LVTAT) was not reduced in any mode versus sinus rhythm. QRS duration was significantly increased by RV pacing versus all other modes (PϽ0.05).
Site Specificity of Response to LV Stimulation
Importance of Zones of Slow Conduction
For each endocardial and epicardial LV lead position, we ascertained whether the lead tip was inside or outside a zone of slow conduction, as defined by NCM. The mean hemodynamic response was expressed as a percentage change from baseline and is shown in Figure 4 , plotted against the LV lead position in relation to the zone of slow conduction.
LV stimulation within an area of slow conduction was associated with a reduction in the degree of hemodynamic response in all LV endocardial pacing configurations (PϽ0.001).
LVTAT and QRS duration were calculated according to the position of the LV lead in or outside of areas of slow conduction. The mean LVTAT when the LV lead was in an area of slow conduction was 78.6Ϯ22.4 ms versus 84.9Ϯ21.8 ms when the lead was not within these areas (Pϭ0.59). The corresponding values for QRS duration were 148.6Ϯ25.5 and 154.9Ϯ32.9 ms, respectively (Pϭ0.95). LV total activation time and QRS duration were not shortened when the LV lead was outside the area of slow conduction, suggesting that mechanism of hemodynamic benefit may be an improvement in mechanical efficiency, which is not underpinned by more rapid electric activation of the myocardium.
Importance of LV Lead Position by Region
For LV endocardial pacing configurations, there was considerable variability in the degree of hemodynamic response in different regions of the LV endocardium. The smallest acute hemodynamic response across all patients in LV-EN mode was 12.6Ϯ10.4% (range, 0% to 28.2%) from baseline and the largest increase was 40.6Ϯ23.0% (range, 16.8% to 92.5%). In BIVEN mode, the smallest increase was 12.8Ϯ10.1% (range, Ϫ0.12% to 29.3%) and the largest was 40.8Ϯ21.9% (range, 16.8% to 90.6%).
The hemodynamic response to pacing in these modes is shown in Figure 5 , according to the relationship of the lead position to areas of slow conduction.
When the LV endocardial lead was outside an area of slow conduction, a lateral position of the LV lead was optimal, with posterior position being the next best. An anterior position of the LV lead gave the least hemodynamic response in this situation. When the LV lead was in an area of slow conduction, the hemodynamic response was superior when the LV lead was placed anteriorly.
Hemodynamic response according to the position of the endocardial LV lead in the long axis of the heart is shown in Figure 6 . There were no significant differences in acute hemodynamic response between basal, mid, and apical LV lead positions. Table 2 summarizes MRI and NCM patient characteristics.
Comparison of NCM With DE-CMR
Ten patients had nonischemic etiology of heart failure on the basis of the history, a normal coronary angiogram, and absence of subendocardial late enhancement on MRI. Of these, none had late gadolinium enhancement of any distribution on CMR. Six of 10 patients with nonischemic cardiomyopathy had lines of conduction block, 17 despite the absence of late enhancement on DE-CMR ( Figure 7 ).
This suggests that DE-CMR is not capable of identifying areas of slow conduction in this patient group. However, late enhancement was demonstrated in all 5 patients with ischemic cardiomyopathy. In this group, there was a reasonable correlation between areas of slow conduction and distribution of scar, as shown in Figure 8 .
Discussion
Hemodynamic Effects of Endocardial and Epicardial Pacing
This small mechanistic study demonstrates that endocardial LV pacing has the potential to confer a superior hemodynamic benefit compared with conventional CRT delivered from the coronary sinus. The degree of acute hemodynamic response at the optimal site was surprisingly high in both endocardial and epicardial LV pacing configurations (79.8Ϯ49.0% and 59.6Ϯ49.5%, respectively). This reflects the fact that this was a highly selected population with marked LV dyssynchrony (with mean QRS duration of 164 ms) in which a nonischemic heart failure etiology predominated. Furthermore, comparison was made with baseline sinus rhythm rather than fixed rate atrial pacing, so a proportion of this percentage increase may be secondary to rate-dependent changes in LV dP/dt. Importantly, the site of optimal benefit differs widely between patients. Pacing within areas of slow conduction was associated with a lesser degree of acute hemodynamic benefit. Areas of fibrosis/scarring correlating with NCM could be seen with DE-CMR in all patients with ischemic cardiomyopathy. However, 60% of patients with nonischemic cardiomyopathy had areas of slow conduction associated with poor response that could not be predicted using DE-CMR.
These findings are in keeping with those of a recent acute hemodynamic study 5 that demonstrated that endocardial and epicardial pacing in the same region of the left ventricle gave rise to similar improvements in LV dP/dt max. Garrigue et al 18 evaluated the chronic effects of biventricular endocardial pacing and demonstrated improved systolic performance with this approach compared with conventional CRT. One key mechanism of potential benefit of endocardial over epicardial pacing may be that this approach facilitates pacing outside areas of slow conduction because a greater area of the myocardium is accessible when lead delivery is not constrained by the coronary venous anatomy. In addition, an endocardial to epicardial mechanical activation is more physiological. Endocardial pacing reproduces the gradient of LV contraction in systole in an endocardial to epicardial direction 19 engaging the subendocardial Purkinje network. This may result in more rapid myocardial recruitment, maximizing the contractile response of the viable recruited myocytes. The difference between the angles of fiber orientation between the endocardial and epicardial layers could also facilitate this more rapid myocardial recruitment.
Electric Versus Mechanical Mechanisms of Benefit
We have also demonstrated that the acute hemodynamic benefit from LV pacing is independent of LV endocardial activation time, which is not reduced in comparison with sinus rhythm. These findings suggest that the mechanism of acute hemodynamic benefit may be more effective mechanical recruitment of the LV myocardium rather than shortening of the LV electric activation time. Detailed MR and mapping studies in the canine ventricle have also shown that mechanical benefit occurs independent of electric resynchronization. 20 Clinically, the concept that mechanical resynchronization is a more important mechanism of benefit of CRT is supported by the fact that positioning of the LV lead at the site of latest mechanical activation confers the maximal clinical benefit. 3, 21 The magnitude of the hemodynamic response will depend on the rate of myocardial recruitment, the viability of the contracting tissue, and the proportion of the ventricle that can contribute to the stroke volume.
Variations in Hemodynamic Response to LV Pacing
We have shown that LV lead positioning within zones of slow conduction is associated with a lesser degree of acute hemodynamic response. This is consistent with the results of a previous study that we conducted that evaluated the hemodynamic response from pacing inside and outside zones of slow conduction. 10 This is likely to reflect less effective capture of the myocardium and slower mechanical propagation across the left ventricle. This mechanism may in part explain the significant intraindividual and interindividual variability that has been found in other studies in the optimal LV lead position in patients undergoing CRT. 4, 5 In our study, a lateral position of the LV endocardial lead was shown to be superior to posterior or anterior lead positions when pacing outside areas of slow conduction. This is consistent with the premise that resynchronization therapy is best delivered using a laterally positioned electrode to reverse the effect of LV dyssynchrony, which gives rise to late activation of the lateral LV wall. When the endocardial LV lead was positioned within an area of slow conduction, it appeared that an anterior position may achieve greater hemodynamic benefit than a lateral position. This is in keeping with the finding in other studies of patients with ischemic cardiomyopathy that positioning the LV lead in an area of posterolateral scar confers an adverse outcome. 7, 22, 23 
Electroanatomic and MRI Correlates
The relationship between myocardial scar and areas of late enhancement on DE-CMR in patients with ischemic cardiomyopathy is well known. 24 In our study, there was a correlation between areas of scar and zones of slow conduction, as previously noted. 11 Myocardial fibrosis can also be visualized using this technique in patients with nonischemic cardiomyopathy in some cases. 12 However, in our study, areas of slow conduction were demonstrated using NCM in 60% of patients with Table 2 
. MRI and NCM Patient Characteristics
nonischemic cardiomyopathy in whom no late enhancement was seen using DE-CMR. It is feasible that cardiac MR is not capable of detecting the low degrees of diffuse fibrosis, which are thought to be associated with slow conduction in this condition. 25 Late gadolinium enhancement using CMR remains a qualitative rather than quantitative evaluation. It provides a relative comparison of degrees of scarring or fibrosis in different regions. As a result, homogeneous diffuse fibrosis at the microscopic level may not manifest as late enhancement to the observer. An alternative explanation for the failure of CMR to detect zones of slow conduction is that fibrosis is not present in these areas but that other properties of the myocardium are affected by the disease process. This may include gap junction or ion channel remodeling, which interfere with activation wave front propagation.
Clinical Implications
Current understanding of response to CRT in patients with ischemic cardiomyopathy is that overall scar burden as well as scar density in proximity to the LV lead tip are associated with an adverse or diminished clinical or echocardiographic response to CRT. 7, 26, 27 Our findings suggest that the presence of areas of slow conduction may account for the variability in response to LV pacing in nonischemic as well as ischemic cardiomyopathy. Although these areas can be visualized in ischemic cardiomyopathy using DE-CMR, this is not the case for patients with nonischemic cardiomyopathy. This is a potential explanation for lack of response to CRT in a significant proportion of this patient population and reinforces the need for positioning the LV lead on an individual basis. An alternative approach to addressing this problem is the use of multipolar leads or multisite pacing, thereby avoiding areas of slow conduction that are associated with a diminished response.
Our data suggest that the principal mechanism of acute hemodynamic benefit from CRT is an improvement in LV mechanical rather than electric activation. Endocardial LV or biventricular pacing gives rise to a superior hemodynamic response compared to conventional CRT. The clinical utility of this approach remains limited at present due to the risk of thromboembolic complications and left-sided valvular endocarditis.
However, when transvenous delivery of the coronary sinus lead has failed, endocardial pacing represents a viable alternative to surgical LV lead placement, in particular if the risks of general anesthetic are high. Another group of patients who may benefit from this approach are nonresponders to conven- tional CRT without suitable coronary venous anatomy for epicardial lead placement.
Study Limitations
Our study involved a small population of carefully characterized of patients, and further work is required to confirm these findings in a larger population. Our protocol incorporated pacing endocardially in the left ventricle at multiple sites to assess the effect of different endocardial positions. The order of pacing sites was not randomly selected and therefore this could be a source of bias. We have acquired information on LV endocardial activation times and QRS duration (reflecting biventricular activation). We do not have full information on transmural LV activation, which would be too invasive to acquire in vivo. It is recognized that the accuracy of NCM reduces with increasing cavity size of the LV, which represents an important limitation in this study of patients with LV dilatation. The mean equatorial distance from the center of the array to the endocardial surface in this study was 37Ϯ11 mm. In the study by Schilling et al 16 validating NCM against contact electrograms, perfect timing matches were obtained as far as 52 mm from the center of the array, although differences in timing of electrograms increased gradually at distances over 34 mm. Chamber dilatation may therefore be anticipated to affect accuracy of activation time measurement rather than identification of regions of slow conduction.
Conclusions
Endocardial CRT may offer a potential for a superior response in patients undergoing CRT. Our data suggest that the response to endocardial pacing is site-specific and is negatively affected by stimulation within area of slow conduction or fibrosis. In patients with ischemic cardiomyopathy, DE-CMR can identify these areas and may be used to guide LV lead placement. DE-CMR was not able to detect areas of slow conduction in patients with nonischemic cardiomyopathy. It is feasible that LV lead positioning within such areas would confer an adverse response to therapy, analogous to positioning of the LV lead in an area of scar in patients with ischemic cardiomyopathy. Therefore, this may represent a mechanism of nonresponse to CRT in this patient group. 
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